NO20001634D0 - Endotelinantagonist- og <beta>-reseptor blokkerende middel som kombinertpreparater - Google Patents

Endotelinantagonist- og <beta>-reseptor blokkerende middel som kombinertpreparater

Info

Publication number
NO20001634D0
NO20001634D0 NO20001634A NO20001634A NO20001634D0 NO 20001634 D0 NO20001634 D0 NO 20001634D0 NO 20001634 A NO20001634 A NO 20001634A NO 20001634 A NO20001634 A NO 20001634A NO 20001634 D0 NO20001634 D0 NO 20001634D0
Authority
NO
Norway
Prior art keywords
beta
blocking agent
receptor blocking
endothelin antagonist
combined preparations
Prior art date
Application number
NO20001634A
Other languages
English (en)
Other versions
NO20001634L (no
NO319048B1 (no
Inventor
Michael Kirchengast
Klaus Muenter
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20001634D0 publication Critical patent/NO20001634D0/no
Publication of NO20001634L publication Critical patent/NO20001634L/no
Publication of NO319048B1 publication Critical patent/NO319048B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20001634A 1997-09-30 2000-03-29 Kombinasjonspreparat av endotelinantagonist og beta-reseptorblokker, fremgangsmate for fremstilling derav samt anvendelse derav for behandling av sykdommer. NO319048B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19743143A DE19743143A1 (de) 1997-09-30 1997-09-30 Pharmazeutische Kombinationspräparate
PCT/EP1998/005772 WO1999016444A1 (de) 1997-09-30 1998-09-10 Endothelin-antagonist und betarezeptorenblocker als kombinationspräparate

Publications (3)

Publication Number Publication Date
NO20001634D0 true NO20001634D0 (no) 2000-03-29
NO20001634L NO20001634L (no) 2000-03-29
NO319048B1 NO319048B1 (no) 2005-06-06

Family

ID=7844115

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001634A NO319048B1 (no) 1997-09-30 2000-03-29 Kombinasjonspreparat av endotelinantagonist og beta-reseptorblokker, fremgangsmate for fremstilling derav samt anvendelse derav for behandling av sykdommer.

Country Status (17)

Country Link
US (1) US6352992B1 (no)
EP (1) EP1019055B1 (no)
JP (1) JP4608093B2 (no)
KR (1) KR100623122B1 (no)
CN (1) CN1149087C (no)
AT (1) ATE239479T1 (no)
AU (1) AU739860B2 (no)
BR (1) BR9812404A (no)
CA (1) CA2304698C (no)
CZ (1) CZ298745B6 (no)
DE (2) DE19743143A1 (no)
ES (1) ES2199461T3 (no)
HK (1) HK1032355A1 (no)
HU (1) HU226745B1 (no)
NO (1) NO319048B1 (no)
RU (1) RU2213577C2 (no)
WO (1) WO1999016444A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
DK1243262T3 (da) 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter
EP1243263B1 (en) 2001-03-21 2002-11-27 Schwarz Pharma Ag Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
KR20070007931A (ko) 2004-04-16 2007-01-16 쉬바르츠파르마에이지 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도
EA014055B1 (ru) 2004-08-27 2010-08-30 Шварц Фарма Аг Применение пептидных соединений для лечения боли при раке кости, а также боли, вызванной химиотерапией и нуклеозидами
US20070196510A1 (en) * 2006-02-17 2007-08-23 Gerber Michael J Method for treating resistant hypertension
TWI397417B (zh) 2006-06-15 2013-06-01 Ucb Pharma Gmbh 具有協同抗驚厥功效之醫藥組成物
CA2904447C (en) 2007-08-22 2017-01-03 Abbvie Deutschland Gmbh & Co Kg Therapy for complications of diabetes
CN104887645B (zh) * 2015-06-15 2016-12-14 吉林万通药业集团梅河药业股份有限公司 阿莫西林胶囊及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786441A (en) * 1987-08-24 1988-11-22 International Business Machines Corporation Preparation of iodonium and sulfonium triflates
SE8704081D0 (sv) * 1987-10-21 1987-10-21 Haessle Ab A new prohylactic method
ATE189217T1 (de) * 1993-03-19 2000-02-15 Merck & Co Inc Phenoxyphenylessigsäurederivate
WO1995020568A1 (en) * 1994-01-28 1995-08-03 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1609477B1 (en) 1994-12-12 2011-11-09 Omeros Corporation Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
NZ298853A (en) 1995-01-27 1998-07-28 Rhone Poulenc Rorer Ltd 5-[2-cyano-phenoxy]-2-phenyl-acetic acid derivatives
DE19636046A1 (de) * 1996-09-05 1998-03-12 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten
DE19652374A1 (de) * 1996-12-04 1998-06-10 Schering Ag Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
KR20000057642A (ko) * 1996-12-18 2000-09-25 스타르크, 카르크 헤테로시클릭 카르복실산 유도체, 그의 제제 및 엔도텔린 수용체길항제로서의 용도

Also Published As

Publication number Publication date
CN1272786A (zh) 2000-11-08
AU739860B2 (en) 2001-10-25
KR100623122B1 (ko) 2006-09-12
RU2213577C2 (ru) 2003-10-10
ATE239479T1 (de) 2003-05-15
EP1019055A1 (de) 2000-07-19
ES2199461T3 (es) 2004-02-16
CZ298745B6 (cs) 2008-01-16
BR9812404A (pt) 2000-09-19
EP1019055B1 (de) 2003-05-07
KR20010015650A (ko) 2001-02-26
CA2304698A1 (en) 1999-04-08
HUP0004590A2 (hu) 2001-11-28
CA2304698C (en) 2008-02-19
DE19743143A1 (de) 1999-04-01
NO20001634L (no) 2000-03-29
NO319048B1 (no) 2005-06-06
AU9267298A (en) 1999-04-23
DE59808297D1 (de) 2003-06-12
JP2001517703A (ja) 2001-10-09
US6352992B1 (en) 2002-03-05
HUP0004590A3 (en) 2002-01-28
HU226745B1 (en) 2009-09-28
CZ20001081A3 (en) 2001-05-16
WO1999016444A1 (de) 1999-04-08
HK1032355A1 (en) 2001-07-20
JP4608093B2 (ja) 2011-01-05
CN1149087C (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
DE60220441D1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
NO994177D0 (no) Atropisomere av 3-aryl-4(3H)-kinazoloner og deres anvendelse som AMPA-reseptor-antagonister
DK0856001T3 (da) Pyrimidinderivater som 5-HT2C-receptor-antagonister
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
TR199501387A2 (tr) Alfa1-adrenerjik reseptör antagonistleri olarak, yeni £3-(4-fenilpiperazin-1-il) propilamino|-piridin, pirimidin ve benzen türevleri.
NO20001634D0 (no) Endotelinantagonist- og &lt;beta&gt;-reseptor blokkerende middel som kombinertpreparater
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE69320985T2 (de) Stabil transfizierte zelllinien welche gaba-a rezeptoren exprimieren
ATE359793T1 (de) 2-methyl-thieno-benzodiazepin formulierung
NO976143D0 (no) Anvendelse av minst en &lt;beta&gt;-adrenergisk agonist som en P substans antagonist
IT1293910B1 (it) Bracciolo di sedia, e sedia utilizzante tale bracciolo.
BR9815335A (pt) Uso de antagonistas de receptor de endotelina.
NO20001548D0 (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
NO996268L (no) Nye &lt;beta&gt;-amino- og &lt;beta&gt;-azidokarboksylsyrederivater, fremstilling derav og anvendelse derav som endothelinreseptorantagonister
AU3386199A (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
NO20032415D0 (no) Forbindelser som er aktive på glukokortikoidreseptor II
NO20021000L (no) Mesoprogestiner (progesteronreseptormodulatorer) som en komponent i preparater for hormonerstatningsterapi (HRT)
NO20000324D0 (no) Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister
DK0938330T3 (da) Anvendelse af LH-RH antagonister som diagnostisk middel
NO952483D0 (no) Seskviterpener, deres fremstilling og anvendelse som inhibitorer innvirkende på gababenzodiazepinreseptorer
NO991174L (no) Anvendelse av proteiner som anti-retrovirale midler
FI963271A (fi) 2-(4-metoksifenoksi)-3-pyridiiniamiini, sen valmistus ja sen käyttö tulehduslääkkeenä
KR970049047U (ko) 위생용 반지 양말

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ABBVIE DEUTSCHLAND GMBH & CO AG, DE

MM1K Lapsed by not paying the annual fees